CAS 951151-97-6

Formel: C15H17ClN6O3

InChl: InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+

InChI Key: BJHCYTJNPVGSBZ-QPSGOUHRSA-N

SMILES: CCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC(=C2/C=N/OC)N)Cl

1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea

CAS: 951151-97-6

Formel: C₁₅H₁₇ClN₆O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 364.7869

Ref: IN-DA01DNTJ

1-(4-((6-Amino-5-((Methoxyimino)Methyl)Pyrimidin-4-Yl)Oxy)-2-Chlorophenyl)-3-Ethylurea

CAS: 951151-97-6

1-(4-((6-Amino-5-((Methoxyimino)Methyl)Pyrimidin-4-Yl)Oxy)-2-Chlorophenyl)-3-Ethylurea

Formel: C₁₅H₁₇ClN₆O₃

Reinheit: 98%

Molekulargewicht: 364.79

Ref: 54-OR1023011

JNJ-38158471

CAS: 951151-97-6

JNJ-38158471

Formel: C₁₅H₁₇ClN₆O₃

Reinheit: ≥95%

Molekulargewicht: 364.79

Ref: 54-BUP08065

JNJ-38158471

CAS: 951151-97-6

Ref: 7W-GW9904

JNJ-38158471

CAS: 951151-97-6

JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor, inhibits closely related tyrosine kinases such as Ret and Kit .

Formel: C₁₅H₁₇ClN₆O₃

Reinheit: 97.08%

Farbe und Form: White Solid

Molekulargewicht: 364.79

Ref: TM-T22349

JNJ-38158471

CAS: 951151-97-6

1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea

Formel: C₁₅H₁₇ClN₆O₃

Reinheit: 98%

Molekulargewicht: 364.79

Ref: IN-DG01269723

(E)-1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-yloxy)-2-chlorophenyl)-3-ethylurea

CAS: 951151-97-6

Reinheit: 98%

Molekulargewicht: 364.7900085

Ref: 10-F866859

JNJ-38158471

CAS: 951151-97-6

JNJ-38158471 is a tyrosine kinase inhibitor that has been shown to have anticancer activity. It can be used for the treatment of cancers, including primary resistance. JNJ-38158471 modulates the activity of growth factors, such as vascular endothelial growth factor and hepatocyte growth factor, which are involved in tumor angiogenesis and tumor cell proliferation. This drug also interacts with factor receptors on cells, which may lead to the termination of their signaling pathways. The oral formulation of JNJ-38158471 has been found to be safe and well tolerated in preclinical studies in mice. This drug is also selective for cancer cells, not affecting normal cells.

Formel: C₁₅H₁₇ClN₆O₃

Reinheit: Min. 95%

Molekulargewicht: 364.79 g/mol

Ref: 3D-BNB15197